Hookipa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary

Hookipa Pharma

11/08/2022 14:33

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 23 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 36 cents per share.
    * Revenue fell 48.9% to $2.75 million from a year ago;
analysts
expected $3.56 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * HOOKIPA Pharma Inc shares had fallen by 3.1% this
quarter and
lost 32.2% so far this year.
    * The company reported a quarterly loss of $16.36 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.36          -0.23          Beat
 Mar. 31 2022      -0.24          -0.40          Missed
 Dec. 31 2021      -0.58          -0.65          Missed
 Sep. 30 2021      -0.52          -0.61          Missed